Indian insurers seek larger unlisted company investment cap
Indian insurers are lobbying the regulator to base a new unlisted investment limit on total shareholder funds rather than solvency surpluses, a tweak that could channel nearly ₹10,000 crore into private markets.
Indian private insurers are pushing the sector regulator to alter the mathematical basis of a proposed rule governing investments in unlisted companies. The industry wants a new 5% allocation cap to be calculated against total shareholders' funds, a shift from the regulator's initial draft which based the limit strictly on surplus capital remaining after meeting mandatory solvency requirements.
Irdai published its draft guidelines last month, setting a July 10 deadline for industry feedback. Under the regulator's original formulation, insurers could only invest up to 5% of their solvency surplus in eligible private limited companies. To qualify, these target companies must demonstrate a history of profitability and hold a minimum net worth of ₹25 crore.
The industry argues the regulator's baseline is too restrictive to materially impact private markets. "Insurers have asked Irdai to calculate the proposed 5% investment limit on total shareholders' funds rather than only the surplus available after meeting solvency requirements, as they say it would expand insurers' capacity to invest in unlisted companies while remaining within overall prudential limits," said one person familiar with the deliberations.
The mathematical distinction carries significant financial weight. Current regulations severely restrict such allocations, limiting the entire insurance sector's capacity to invest in private companies to less than ₹1,500 crore. Industry calculations show that applying the 5% limit to total shareholders' funds would immediately expand this capacity to nearly ₹10,000 crore.
For India's privately held businesses, this regulatory adjustment represents a potential windfall of domestic institutional capital. Tapping into insurance funds would provide an alternative to traditional private equity or foreign venture capital, offering longer-duration capital that aligns well with the operational timelines of unlisted corporates.
The debate over unlisted investments is part of a wider regulatory overhaul by Irdai aimed at modernizing insurer portfolio management. The draft rules also propose allowing insurers to execute repo transactions to manage short-term liquidity needs. Additionally, Irdai wants to permit participation in government securities lending, giving fund managers the tools to generate incremental returns on sovereign holdings while maintaining overall portfolio flexibility.
